NasdaqGS:GERNBiotechs
Geron (GERN) Is Up 15.6% After Raising 2026 RYTELO Revenue Guidance And Filing New ESOP Shares
In August 2026, Geron Corporation reported second-quarter 2026 results showing revenue of US$57.48 million versus US$49.04 million a year earlier, alongside a six-month net loss of US$20.32 million, and issued 2026 guidance projecting RYTELO net product revenue between US$220 million and US$240 million.
The company also filed a US$6.03 million shelf registration for 4,500,000 common shares tied to an ESOP, highlighting ongoing use of equity-based compensation.
We’ll now examine how Geron’s...